Reducing Inflammatory Markers in Chronic Kidney Disease (CKD) - Role of Probiotics Dr Kartikeya Kohli7 Jan 2023 5:15 AM GMTChronic kidney disease (CKD) affects around one out of every seven persons over 20 (1). CKD is a chronic progressive disease, which means kidney...
Finerenone receives Grade A Recommendation for treating CKD patients associated with type 2 diabetes: AACE update Dr. Kamal Kant Kohli10 Dec 2022 2:30 PM GMTUSA: Bayer's KERENDIA (finerenone), a first-in-class non-steroidal mineralocorticoid receptor antagonist (ns-MRA) has received a grade A...
Is it really healthy to restrict protein intake for kidney transplant recipients? Dr. Kamal Kant Kohli23 Sep 2022 3:00 PM GMTChronic kidney disease patients are known to have induced sarcopenia due to chronic inflammation, hypercatabolism, decreased nutrient intake, and...
Is it really healthy to restrict protein intake for kidney transplant recipients? Isra Zaman17 Sep 2022 3:45 AM GMTConventional wisdom holds that low protein intake is essential for kidney disease patients. However, scientists from Osaka Metropolitan University...
In CKD patients, exercise training program improves cardiorespiratory fitness Dr. Kamal Kant Kohli12 Aug 2022 2:30 PM GMTThis randomized trial recently published in the American Journal of Kidney Diseases (AJKD) found that a 12-month program of in-center aerobic and...
Higher Aldosterone levels increase risk of CKD progression independent of diabetes status Dr. Kamal Kant Kohli10 Aug 2022 2:30 PM GMTAldosterone is a steroid hormone secreted by the adrenal glands whose main role is to regulate salt and water in the body. It plays a central role in...
Aldosterone increases risk of chronic kidney disease progression Dr. Nandita Mohan9 Aug 2022 3:30 AM GMTA steroid hormone called aldosterone is linked to an increased risk of kidney failure in patients with chronic kidney disease. This is in accordance...
High physical activity to reduce the risk of heart disease in CKD patients Isra Zaman9 July 2022 4:00 AM GMTIn a recent long-term study of 3,926 adults with chronic kidney disease (CKD) recently published in the American Journal of Kidney Diseases (AJKD),...
Tirzepatide Slows CKD Progression among diabetes patients with Increased CV risk Dr. Kamal Kant Kohli7 Jun 2022 3:45 AM GMTTirzepatide can slow progression of chronic kidney disease in type 2 diabetes according to an analysis of SURPASS-4 data presented at ADA 2022. In...
Dapagliflozin reduces Renal Risk in CKD, irrespective of Diabetes Status: NEJM Dr Satabdi Saha25 Sep 2020 3:28 PM GMTThe sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin reduces the risk for kidney disease progression and death in patients with chronic...
Phosphate binders don't reduce risk of heart disease in CKD patients: IMPROVE-CKD trial Dr. Kamal Kant Kohli14 Sep 2020 2:29 PM GMTResearchers have found in large-scale IMPROVE-CKD clinical trial that lanthanum carbonate does not reduce the risk of cardiovascular disease...
